Comparison of Different Dose of Anti-T Lymphocyte Globulin (ATLG) in Haploidentical HSCT for GVHD Prophylaxis
- Conditions
- Hematopoietic Stem Cell Transplantation
- Interventions
- Drug: ATLG
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-29
- Target Recruit Count
- 104
- Registration Number
- NCT06525519
- Locations
- 🇨🇳
The Southwest Hospital of Amu, Chongqing, Chongqing, China
🇨🇳The First Bethune Hospital of Jilin University, Jilin, Jilin, China
🇨🇳Tai'an City Central Hospital, Taian, Shandong, China
Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-07-22
- Target Recruit Count
- 45
- Registration Number
- NCT06513234
- Locations
- 🇨🇳
China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, China
The Use of Blinatumomab in Patients With NGS-MRD Relapsed B-ALL After Autologous/Allogeneic Transplantation
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-07-16
- Target Recruit Count
- 20
- Registration Number
- NCT06504186
Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma
- Conditions
- Mantle Cell Lymphoma
- Interventions
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-08-09
- Target Recruit Count
- 39
- Registration Number
- NCT06504199
- Locations
- 🇨🇳
Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin, China
🇨🇳Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences, Tianjin, Tianjin, China
Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI
- Conditions
- Acute Graft-versus-host Disease
- Interventions
- Drug: PDCyDrug: Non Cy
- First Posted Date
- 2024-07-08
- Last Posted Date
- 2024-07-08
- Target Recruit Count
- 66
- Registration Number
- NCT06490562
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
- Conditions
- Relapsed/Refractory Large B-Cell Lymphoma
- Interventions
- First Posted Date
- 2024-07-08
- Last Posted Date
- 2024-07-08
- Target Recruit Count
- 89
- Registration Number
- NCT06489808
- Locations
- 🇨🇳
Institute of Hematology & Blood Disease Hospital, Tianjin, Tianjin, China
An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)
- Conditions
- RSV Infection
- First Posted Date
- 2024-07-08
- Last Posted Date
- 2024-07-08
- Target Recruit Count
- 500
- Registration Number
- NCT06490549
- Locations
- 🇨🇳
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell Transplantation
- Conditions
- Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-25
- Target Recruit Count
- 20
- Registration Number
- NCT06484049
Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL
- Conditions
- Philadelphia Positive Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, Adult
- Interventions
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-01
- Target Recruit Count
- 82
- Registration Number
- NCT06481228
- Locations
- 🇨🇳
Institute of Hematology & Blood Diseases Hospital, Tianjin, China
Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL
- Conditions
- Philadelphia Chromosome Negative ALLAcute Lymphoblastic Leukemia, Adult
- Interventions
- Combination Product: CAR-T cells
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-03-06
- Target Recruit Count
- 77
- Registration Number
- NCT06481241
- Locations
- 🇨🇳
Institute of Hematology & Blood Diseases Hospital, Tianjin, China